Table 3.
GEE parameter estimates for Total Bilirubin predicting transplantation or death.
| Parameter | Estimate | Odds Ratio | p-value | 95% Confidence Limits for Odds Ratio | |
|---|---|---|---|---|---|
| Placebo 3-4 | 1.32 | 3.75 | 0.0016 | 1.36 | 10.36 |
| NAC 3-4 | 2.28 | 9.74 | 2.03 | 46.61 | |
| Placebo 1-2 | 1.06 | 2.89 | 1.25 | 6.64 | |
| NAC 1-2* | 0.00 | 1.00 | |||
| Day 1 | 0.27 | 1.31 | 0.0290 | 1.09 | 1.58 |
| Day 2 | 0.21 | 1.24 | 1.03 | 1.49 | |
| Day 3 | 0.09 | 1.09 | 0.93 | 1.29 | |
| Day 4** | 0.00 | 1.00 | |||
| Total Bilirubin | 0.06 | 1.06 | 0.0030 | 1.02 | 1.10 |
Using NAC 1-2 as the reference group, all other groups show positive estimate values indicating higher likelihood of death or transplant. Day 4 is the reference day that is then compared with the prior 3 days. The effect is greatest on day 1 and declines over succeeding days.
Reference group for Treatment/Coma combination
Reference group for Days 1-3